Ciccarese, Chiara
 Distribuzione geografica
Continente #
AS - Asia 813
NA - Nord America 731
EU - Europa 398
SA - Sud America 199
AF - Africa 25
OC - Oceania 2
Totale 2.168
Nazione #
US - Stati Uniti d'America 696
SG - Singapore 306
CN - Cina 174
BR - Brasile 172
IT - Italia 111
VN - Vietnam 94
SE - Svezia 71
IN - India 59
DE - Germania 52
BD - Bangladesh 51
FR - Francia 49
GB - Regno Unito 27
JP - Giappone 26
HK - Hong Kong 22
IE - Irlanda 19
CA - Canada 16
ID - Indonesia 16
MX - Messico 16
PL - Polonia 14
KR - Corea 13
IQ - Iraq 12
RU - Federazione Russa 11
AR - Argentina 8
NL - Olanda 8
ZA - Sudafrica 8
EC - Ecuador 7
ES - Italia 7
TR - Turchia 7
FI - Finlandia 6
EG - Egitto 5
SA - Arabia Saudita 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
LT - Lituania 4
VE - Venezuela 4
CL - Cile 3
DZ - Algeria 3
MM - Myanmar 3
PH - Filippine 3
PK - Pakistan 3
AU - Australia 2
CI - Costa d'Avorio 2
CO - Colombia 2
ET - Etiopia 2
IR - Iran 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
PS - Palestinian Territory 2
PY - Paraguay 2
RO - Romania 2
SI - Slovenia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AT - Austria 1
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
GT - Guatemala 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
LU - Lussemburgo 1
NP - Nepal 1
PA - Panama 1
RS - Serbia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 2.168
Città #
Singapore 148
San Jose 125
Ashburn 88
Chandler 44
Hefei 38
Ho Chi Minh City 38
Hyderabad 35
Beijing 34
Los Angeles 28
Frankfurt am Main 27
Tokyo 25
Hanoi 23
Lauterbourg 22
Rome 22
Hong Kong 21
New York 20
Dublin 19
São Paulo 19
Milan 16
Seoul 13
Jakarta 12
The Dalles 12
Chicago 11
Kent 10
Orem 10
Santa Clara 10
Warsaw 10
Düsseldorf 9
Mexico City 9
Brooklyn 8
Chennai 8
Dallas 8
Houston 8
Johannesburg 7
Boston 6
Buffalo 6
Dearborn 6
Denver 6
Dhaka 6
Poplar 6
Porto Alegre 6
Princeton 6
Toronto 6
Baghdad 5
Boardman 5
Curitiba 5
Da Nang 5
Munich 5
Seattle 5
Ankara 4
Atlanta 4
Falkenstein 4
Helsinki 4
Jeddah 4
Moscow 4
Nanjing 4
Portsmouth 4
Rio de Janeiro 4
Secaucus 4
Stockholm 4
Wilmington 4
Amsterdam 3
Belo Horizonte 3
Bexley 3
Bologna 3
Brescia 3
Cairo 3
Guayaquil 3
Haiphong 3
Hebei 3
Montreal 3
Querétaro 3
Recife 3
Redwood City 3
San Mateo 3
Shanghai 3
São Gonçalo 3
Uberlândia 3
Abidjan 2
Addis Ababa 2
Alghero 2
Amman 2
Berlin 2
Bắc Ninh 2
Canaã dos Carajás 2
Cleveland 2
Columbus 2
Concord 2
Cruzeiro 2
Dubai 2
Duncan 2
Erbil 2
Florence 2
Greensboro 2
Guaratinguetá 2
Hải Dương 2
Karachi 2
Lappeenranta 2
Little Rock 2
Ljubljana 2
Totale 1.164
Nome #
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers 129
Biomarkers of response to advanced prostate cancer therapy 125
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy 124
Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives 122
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 120
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study 115
Current evidence for second-line treatment in metastatic renal cell carcinoma after progression to immune-based combinations 114
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 108
Cabozantinib-related cardiotoxicity: a prospective analysis in a real-world cohort of metastatic renal cell carcinoma patients 105
Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy 103
Management of metastatic urothelial carcinoma: Current approach, emerging agents, and future perspectives 98
Cabozantinib-related pneumothorax in rapidly responding patients with renal cell carcinoma 95
Patients with sarcomatoid renal cell carcinoma – re-defining the first-line of treatment: A meta-analysis of randomised clinical trials with immune checkpoint inhibitors 94
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis 91
Prostate cancer heterogeneity: Discovering novel molecular targets for therapy 90
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin 84
Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario 84
New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis 83
Triplet therapy with androgen deprivation, docetaxel, and androgen receptor signalling inhibitors in metastatic castration-sensitive prostate cancer: A meta-analysis 83
Revising PTEN in the era of immunotherapy: New perspectives for an old story 76
Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis 75
Diagnostic Biopsy for Small Renal Tumours: A Survey of Current European Practice 57
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial 14
Patient-derived organoids in renal cell carcinoma: A review of methodologies and applications 9
A novel comprehensive cancer genome profiling for non-metastatic prostate cancer: study protocol with FPG500 to detect actionable alterations representative of progressive disease 5
Liquid Biopsy in Non-Metastatic Prostate Cancer: Clinical Evidence and Future Directions 5
Totale 2.208
Categoria #
all - tutte 8.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.847


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202245 4 0 3 4 6 0 0 6 1 1 14 6
2022/2023135 26 22 8 12 15 8 9 12 14 1 3 5
2023/202498 6 21 3 11 4 11 4 0 7 3 13 15
2024/2025456 3 1 16 8 6 9 47 17 45 83 103 118
2025/20261.431 199 64 84 200 220 57 178 87 76 88 108 70
Totale 2.208